Clinical Implications of Next-Generation Sequencing for Cancer Medicine
1
Department of Medical Genetics, McGill University Health Centre, McGill University, Montreal, QC H3G 1A4, Canada
2
Departments of Oncology and Human Genetics, McGill University, Montreal, QC, Canada
*
Author to whom correspondence should be addressed.
Curr. Oncol. 2010, 17(5), 39-42; https://doi.org/10.3747/co.v17i5.630
Submission received: 2 July 2010
/
Revised: 3 August 2010
/
Accepted: 4 September 2010
/
Published: 1 October 2010
Excerpt
Note: In lieu of an abstract, this is an excerpt from the first page.
In 1976, Peter Nowell, following observations of cytogenetic heterogeneity in a population of cancer-ous cells, proposed that this genetic diversity could be explained by hypothesizing that these cells are subject to evolutionary forces[...]
Share and Cite
MDPI and ACS Style
Shuen, A.; Foulkes, W.D. Clinical Implications of Next-Generation Sequencing for Cancer Medicine. Curr. Oncol. 2010, 17, 39-42. https://doi.org/10.3747/co.v17i5.630
AMA Style
Shuen A, Foulkes WD. Clinical Implications of Next-Generation Sequencing for Cancer Medicine. Current Oncology. 2010; 17(5):39-42. https://doi.org/10.3747/co.v17i5.630
Chicago/Turabian StyleShuen, A., and W. D. Foulkes. 2010. "Clinical Implications of Next-Generation Sequencing for Cancer Medicine" Current Oncology 17, no. 5: 39-42. https://doi.org/10.3747/co.v17i5.630
